Affordable Fertility Medication: Cosette Pharmaceuticals and Mark Cuban's Cost Plus Drug Company Partnership

Cosette Pharmaceuticals, a leading pharmaceutical company, has joined forces with Mark Cuban's Cost Plus Drug Company to offer affordable CLOMID® (clomiPHENE citrate) 50mg tablets. This partnership aims to make fertility medication more accessible to couples struggling with infertility. CLOMID® has been a trusted prescription medication for over 50 years, helping millions of women by stimulating hormones that support ovulation. Now, through Cost Plus Drugs' online pharmacy, CLOMID® can be purchased at a low cash price, ensuring affordability for those in need.

Infertility affects nearly 20 percent of couples in the United States. It is often defined as the inability to conceive after 6-12 months of regular, unprotected sex. Recognizing the importance of access and affordability in addressing this issue, Cosette Pharma CEO Apurva Saraf expressed excitement about the partnership with Cost Plus Drugs and the opportunity to provide CLOMID® to patients in a more affordable manner.

Cost Plus Drugs, founded in 2022 by investor-entrepreneur Mark Cuban, is dedicated to reducing the cost of prescription medications. By negotiating prices directly with manufacturers and offering low transparent prices, Cost Plus Drugs aims to make prescription drugs more affordable for everyone. The company's online pharmacy carries a wide range of commonly prescribed medications and has quickly gained popularity among consumers. The collaboration with Cosette Pharmaceuticals marks Cost Plus Drugs' expansion into the branded segment of the US pharmaceutical market.

CLOMID® is just one of the many branded drugs now available through Cost Plus Drugs. This collaboration demonstrates Cosette Pharmaceuticals' commitment to prioritizing access and affordability for patients. By partnering with Cost Plus Drugs, Cosette Pharmaceuticals ensures that CLOMID® remains an accessible option for couples struggling with infertility.

It's important to note that CLOMID® is a prescription medication used to treat ovulatory dysfunction in female adults who want to become pregnant. By increasing the release of certain hormones that aid in egg development and maturation, CLOMID® stimulates ovulation. However, like any medication, it has potential side effects and precautions.

Some common side effects of CLOMID® include enlarged ovaries, hot flashes, abdominal or pelvic discomfort, headaches, nausea, vomiting, and abnormal uterine bleeding. Additionally, there is an increased chance of having multiple pregnancies while taking CLOMID®. It's crucial to consult with a healthcare professional for more information and guidance when considering fertility treatment.

Cosette Pharmaceuticals, a US-based pharmaceutical company, specializes in product development, manufacturing, and commercial operations. With a growing portfolio of branded pharmaceuticals in women's health, cardiology, and dermatology, Cosette Pharmaceuticals has a history of quality manufacturing and is supported by Avista Capital Partners, a healthcare-focused private equity firm. The company is dedicated to meeting the needs of patients through innovation, access, and affordability.

Mark Cuban's Cost Plus Drug Company operates as a public-benefit corporation, emphasizing the improvement of public health alongside financial success. The company transparently charges a standard markup on every drug it sells, ensuring fair prices. Its online pharmacy, launched in 2022, offers over 1,000 prescription products delivered to thousands of customers across the country.

For more information about CLOMID®, including full prescribing information, visit [www.MyClomid.com](https://www.MyClomid.com). To report any side effects related to CLOMID®, contact Cosette Pharmaceuticals, Inc. at 1-800-922-1038 or the Food and Drug Administration (FDA) at 1-800-FDA-1088 or visit [www.fda.gov/medwatch](https://www.fda.gov/medwatch).

In conclusion, the partnership between Cosette Pharmaceuticals and Mark Cuban's Cost Plus Drug Company brings hope to couples struggling with infertility. By making CLOMID® more affordable and accessible through Cost Plus Drugs' online pharmacy, these companies are alleviating some of the financial burdens associated with fertility treatment. This collaboration underscores the commitment of both Cosette Pharmaceuticals and Cost Plus Drug Company to improve healthcare outcomes and provide affordable options for patients in need.